Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-005685-30Phase 4Terminated
Phase 4, randomised trial of methylprednisolone sodium succinate (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Variation of diameter of brachial artery and Peripheral StO2 variation. Started Feb 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-005685-30.